Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1

Journal of Experimental Medicine

Volumn 194, Issue 6, 2001, Pages 809-821

  Chun Geun Lee, ^a   Homer, R J ^a   Zhu, Z ^a   Lanone, S ^a   Wang, X ^a   Koteliansky, V ^a   Shipley, J M ^a   Gotwals, P ^a   Noble, P ^a   Chen, Q ^a   Senior, R M ^a   Elias, J A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; CD44; Lung; Matrix metalloproteinase 9; Plasmin

Indexed keywords

APROTININ; COLLAGEN; GELATINASE B; HERMES ANTIGEN; INTEGRIN; INTERLEUKIN 13; MESSENGER RNA; SERINE PROTEINASE; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG FIBROSIS; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD44; INTERLEUKIN-13; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PULMONARY FIBROSIS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; URINARY PLASMINOGEN ACTIVATOR;

EID: 0035903306     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.194.6.809     Document Type: Article

References (64)

1. Airway wall remodelling in the pathogenesis of asthma: Cytokine expression in the airways
2. Th2 cells and GATA-3 in asthma: New insights into the regulation of airway inflammation
3. Airway remodeling in asthma
4. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis
5. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis
6. Th1/Th2 cells
7. A type 2 (Th2-like) pattern of immune response predonimates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA)
8. A preliminary study of long term treatment with interferon γ-1β and low dose prednisolone in patients with idiopathic pulmonary fibrosis
9. Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat
10. Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role?
11. Lung interleukin-5 expression in murine bleomycin-induced pulmonary fibrosis
12. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response
13. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent
14. IL-10 and the dangers of immune polarization: Excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis
15. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses
16. Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease
17. Molecular mechanisms of antifibrotic effect of interferon γ in bleomycinmouse model of lung fibrosis: Downregulation of TGF-β and procollagen I and III gene expression
18. Interferon-γ inhibits experimental renal fibrosis
19. Fibrosis in the lung and other tissues: New concepts in pathogenesis and treatment
20. The role of IL-13 and its receptor in allergy and inflammatory responses
21. The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes
22. Requirement for IL-13 independently of IL-4 in experimental asthma
23. Interleukin-13 and interleukin-4 are coexpressed in atopic asthma
24. Interleukin-13: Central mediator of allergic asthma
25. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities and eotaxin production
26. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs
27. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung
28. Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: Possible autocrine mechanism and involvement in fibrosis
29. Interleukin (IL)-4 and IL-13 act on human lung fibroblasts
30. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts
31. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
32. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity
33. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema
34. Targeted expression of IL-11 in the murine airway causes airways obstruction, bronchial remodeling and lymphocytic inflammation
35. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor β type II receptor: A potential new therapy for hepatic fibrosis
36. Soluble transforming growth factor-β type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth
37. IL-11 selectively inhibits aeroallergen-induced pulmonary eosinophilia and Th2 cytokine production
38. Histophotometric estimation of volume density of collagen as an indication of fibrosis in rat liver
39. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for wound healing
40. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections
41. TGF-β: From latent to active
42. Post translational activation of latent transforming growth factor β (L-TGF-β): Clinical implications
43. Latent transforming growth factor-β: Structural features and mechanisms of activation
44. The integrin αvβ6 binds and activates latent TGF β1: A mechanism for regulating pulmonary inflammation and fibrosis
45. Transforming growth factor-β (TGF-β)
46. Activation of rat alveolar macrophage-derived latent transforming growth factor β-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36
47. A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat
48. Involvement of u-PA in the antiapoptotic activity of TGF-beta for vascular smooth muscle cells
49. Plasmin regulates the activation of cell-associated latent TGF-β1 secreted by rat alveolar macrophages after in vivo bleomycin injury
50. Proteolytic control of growth factor availability
51. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis
52. Role of elevated plasma transforming growth factor-β1 levels in wound healing
53. Regulation of immune responses by TGF-β
54. Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis
55. TGF-β1, but not TGF-β2 or TGF-β3, is differentially present in epithelial cells of advanced pulmonary fibrosis: An immunohistochemical study
56. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma
57. Molecule of the month. TGF-β: A critical modulator of immune cell function
58. + T cells
59. Matrix metalloproteinase-1 and -9 activation by plasnim regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three dimensional collagen matrices
60. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromolysin-1 cascade enhances tumor cell invasion
61. Involvement of the Ras/MAPK signaling pathway in the modulation of urokinase production and cellular invasiveness by transforming growth factor-β1 in transformed keratinocytes
62. Interleukin (IL)-4-independent induction of immunoglobulin (lg)E, and perturbation of T cell development in transgenic mice expressing IL-13
63. Interleukin-13, an interleukin-4-like cytokine that acts on monocytes and B cells, but not on T cells
64. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells